Guangdong Marubi Biotechnology Co

Guangdong Marubi Biotechnology Co

603983 · SHG · Consumer Defensive / Household & Personal Products

24.30CNY+0.28 (+1.17%)

Price History

Full chart

Market Stats

Previous Close24.02
Open23.92
Day Range23.43 – 24.62
52-Week Range21.20 – 39.77
Volume3.49M
Market Cap12.37B
P/E (TTM)53.21
Forward P/E32.68
EPS0.58
Dividend Yield1.62%
Beta0.10
50-Day Avg29.88
200-Day Avg28.44

About

Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Huaiqing Sun
  • Employees1.38K
  • HeadquartersMarubi Building, Guangzhou, China, 510308, China
  • Websitehttps://www.marubi.cn

Leadership

  • Mr. Huaiqing SunChairman & CEO · b. 1969
  • Mr. Kaihui WangCFO & Director · b. 1971
  • Mr. Lingchun ZengChief Marketing Officer & Director · b. 1978
  • Ms. Di ChengBoard Secretary · b. 1984
  • Dan HuangHead of Accounting Department & Accounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue613.18M814.91M973.74M1.08B1.19B1.21B1.35B1.58B1.80B1.74B1.79B1.73B2.23B2.97B3.46B
Growth (%)-+32.90%+19.49%+10.45%+10.76%+1.42%+11.94%+16.52%+14.28%-3.10%+2.41%-3.10%+28.52%+33.44%+16.48%
Cost of Revenue132.43M206.56M231.77M270.16M373.38M390.58M434.91M502.80M578.89M595.69M654.50M557.04M665.27M793.26M889.52M
Gross Profit480.76M608.36M741.97M805.35M817.85M817.54M917.42M1.07B1.22B1.15B1.13B1.17B1.56B2.18B2.57B
Gross Margin78.40%74.65%76.20%74.88%68.66%67.67%67.84%68.09%67.85%65.86%63.37%67.83%70.11%73.29%74.29%
Operating Expense279.31M395.56M492.17M499.21M504.18M557.24M551.36M588.79M609.32M576.78M833.54M967.34M1.24B1.80B2.32B
Operating Income201.45M212.80M249.80M306.14M313.67M260.31M366.05M484.17M612.65M572.52M298.99M207.34M319.34M380.94M253.91M
Operating Margin32.85%26.11%25.65%28.46%26.33%21.55%27.07%30.73%34.02%32.81%16.73%11.97%14.35%12.83%7.34%
EBITDA199.76M211.50M246.98M298.98M298.44M257.84M349.41M426.61M541.18M450.59M231.83M154.13M192.17M360.74M362.03M
EBITDA Margin32.58%25.95%25.36%27.80%25.05%21.34%25.84%27.07%30.05%25.82%12.97%8.90%8.63%12.15%10.47%
Net Income167.26M186.88M218.61M271.37M281.43M232.19M311.92M415.28M514.89M464.40M247.92M174.18M259.42M341.63M247.24M
Net Income Margin27.28%22.93%22.45%25.23%23.63%19.22%23.07%26.35%28.59%26.61%13.87%10.06%11.66%11.50%7.15%
R&D-----24.80M28.30M33.82M44.87M50.15M50.49M52.93M62.29M73.54M85.37M
R&D as % of Total Revenue-----2.05%2.09%2.15%2.49%2.87%2.83%3.06%2.80%2.48%2.47%
Interest Expense-----119.11K222.92K7.43M299.12K1.13M1.02M3.52M7.04M10.35M3.28M
Interest Expense % of Total Revenue-----0.01%0.02%0.47%0.02%0.07%0.06%0.20%0.32%0.35%0.09%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets596.96M704.69M939.25M1.20B1.37B1.48B1.60B2.12B3.44B3.80B3.76B4.09B4.45B5.06B4.61B
Total Liabilities448.94M469.82M486.14M597.49M649.88M647.79M643.00M735.02M766.40M794.44M603.19M838.64M1.04B1.62B1.22B
Total Equity147.62M234.49M453.11M604.48M715.92M828.09M959.96M1.38B2.67B2.98B3.08B3.19B3.35B3.38B3.33B
Cash363.54M386.93M545.13M756.74M849.83M941.47M1.10B1.56B2.10B1.67B806.10M1.07B1.08B2.03B1.25B
Total Debt----15.60M20.60M---106.70M19.47M270.44M255.48M791.61M-
Net Debt-363.54M-386.93M-545.13M-756.74M-834.23M-920.87M-1.10B-1.56B-2.10B-1.56B-786.63M-802.57M-821.25M-1.24B-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow269.39M227.49M325.67M376.24M275.11M213.33M356.20M516.69M465.53M362.35M-7.48M48.44M338.02M300.53M273.88M
Investing Cash Flow-123.65M-104.10M-67.10M-44.63M-12.02M-6.61M5.98M-56.24M-699.45M-782.10M-681.14M70.14M-215.16M432.19M-
Financing Cash Flow300.00K-100.00M-100.37M-120.00M-154.40M-115.00M-200.60M771.98M771.98M-24.85M-169.84M144.92M-134.95M-193.15M-
Capital Expenditure125.59M79.34M67.10M44.63M12.08M6.62M6.39M11.34M6.42M748.91M117.14M110.91M254.05M316.37M205.25M
Free Cash Flow143.80M148.15M258.57M331.61M263.04M206.72M349.81M505.35M459.11M-386.57M-124.62M-62.47M83.98M-15.85M68.63M
Dividends Paid-100.00M100.00M120.00M170.00M120.00M180.00M156.83M156.83M156.83M141.92M76.19M106.11M313.16M300.89M
FCF to OCF53.38%65.12%79.40%88.14%95.61%96.90%98.21%97.80%98.62%-106.69%1665.89%-128.98%24.84%-5.27%25.06%
Dividend Paid to FCF-67.50%38.67%36.19%64.63%58.05%51.46%31.03%34.16%-40.57%-113.88%-121.96%126.35%-1976.06%438.43%

Earnings

Report DateApr 29, 2019Aug 28, 2019Oct 29, 2019Apr 21, 2020Aug 27, 2020Oct 28, 2020Dec 31, 2020Apr 23, 2021Aug 27, 2021Oct 29, 2021Dec 31, 2021Apr 29, 2022Aug 26, 2022Oct 28, 2022Dec 31, 2022Apr 28, 2023Oct 30, 2023Dec 31, 2023Apr 26, 2024Jun 30, 2024Oct 25, 2024Apr 25, 2025Aug 22, 2025Sep 30, 2025Mar 31, 2026Aug 28, 2026
EPS Estimate0.00--0.27--0.520.520.420.200.150.150.230.070.280.280.140.240.240.230.190.240.280.160.360.18
EPS Actual1.150.330.260.400.370.170.320.330.22-0.120.260.270.130.010.130.130.100.220.220.160.160.250.120.150.010.14
Surprise---48.15%---38.46%-36.54%-47.62%-160.00%73.33%80.00%-43.48%-85.71%-53.57%-53.57%-28.57%-8.33%-8.33%-30.43%-15.79%4.17%-57.14%-4.88%-97.22%-22.22%
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market-After-hoursAfter-hoursPre-market-After-hoursPre-market-After-hours-Pre-marketPre-marketPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap12.37B
Enterprise Value11.06B
Trailing P/E53.21
Forward P/E32.68
PEG Ratio1.51
Price / Sales3.69
Price / Book3.69
EPS0.58
Book Value8.43
Revenue (TTM)3.36B
Gross Profit (TTM)2.47B
EBITDA206.68M
Profit Margin6.80%
Operating Margin-0.18%
Return on Equity6.67%
Return on Assets1.78%
Shares Outstanding401.00M
Shares Float77.00M
Beta0.10
Dividend Yield1.62%
Dividend Rate0.50
Payout Ratio43.10%

Dividends

20231×
0.25Jul 19, 2023
20221×
0.19Jul 21, 2022
20211×
0.35Jul 7, 2021
20201×
0.39Jul 1, 2020